You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
2023 FDA approvals
|
|---|---|
| Published by |
Nature Reviews Drug Discovery, January 2024
|
| DOI | 10.1038/d41573-024-00001-x |
| Pubmed ID | |
| Authors |
Asher Mullard |
X Demographics
The data shown below were collected from the profiles of 317 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 67 | 21% |
| Spain | 17 | 5% |
| United Kingdom | 13 | 4% |
| Japan | 10 | 3% |
| Germany | 7 | 2% |
| France | 5 | 2% |
| Mexico | 4 | 1% |
| India | 4 | 1% |
| Saudi Arabia | 3 | <1% |
| Other | 44 | 14% |
| Unknown | 143 | 45% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 226 | 71% |
| Scientists | 71 | 22% |
| Practitioners (doctors, other healthcare professionals) | 15 | 5% |
| Science communicators (journalists, bloggers, editors) | 5 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 56 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 6 | 11% |
| Student > Bachelor | 6 | 11% |
| Student > Doctoral Student | 5 | 9% |
| Professor > Associate Professor | 5 | 9% |
| Student > Master | 5 | 9% |
| Other | 8 | 14% |
| Unknown | 21 | 38% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 10 | 18% |
| Chemistry | 7 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 7% |
| Business, Management and Accounting | 2 | 4% |
| Nursing and Health Professions | 2 | 4% |
| Other | 7 | 13% |
| Unknown | 24 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 219. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 May 2024.
All research outputs
#183,988
of 26,150,897 outputs
Outputs from Nature Reviews Drug Discovery
#75
of 3,737 outputs
Outputs of similar age
#2,812
of 371,322 outputs
Outputs of similar age from Nature Reviews Drug Discovery
#3
of 61 outputs
Altmetric has tracked 26,150,897 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,737 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 371,322 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 61 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.